Table of Contents Author Guidelines Submit a Manuscript
Case Reports in Medicine
Volume 2010 (2010), Article ID 395720, 4 pages
http://dx.doi.org/10.1155/2010/395720
Case Report

Metronomic Treatment with Low-Dose Trofosfamide Leads to a Long-Term Remission in a Patient with Docetaxel-Refractory Advanced Metastatic Prostate Cancer

1Department of Internal Medicine III, University of Ulm, Albert Einstein-Allee 23, 89081 Ulm, Germany
2Department of Urology, University of Ulm, Robert-Koch-Str. 8, 89081 Ulm, Germany
3Department of Nuclear Medicine, University of Ulm, Robert-Koch-Str. 8, 89081 Ulm, Germany
4Internal Medicine, Clinic of Dinkelsbühl, Germany
5IIIrd Department of Medicine, Clinic of Karlsruhe, 76133 Karlsruhe, Germany

Received 23 June 2009; Revised 25 February 2010; Accepted 15 March 2010

Academic Editor: Jonathan Melamed

Copyright © 2010 Jochen Greiner et al. This is an open access article distributed under the Creative Commons Attribution License, which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited.

How to Cite this Article

Jochen Greiner, Rainer Küfer, Sven N. Reske, Volker Martin, Hartmut Döhner, and Mark Ringhoffer, “Metronomic Treatment with Low-Dose Trofosfamide Leads to a Long-Term Remission in a Patient with Docetaxel-Refractory Advanced Metastatic Prostate Cancer,” Case Reports in Medicine, vol. 2010, Article ID 395720, 4 pages, 2010. doi:10.1155/2010/395720